Advanced search
Publication Cover
HIV/AIDS - Research and Palliative Care Volume 13, 2021 - Issue
Submit an article Journal homepage
154
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study

Peize Zhang1 Department of Lung Disease, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4023-0228View further author information
ORCID Icon,
HouMing Liu2 Department of Clinical Laboratory, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Hui Wang3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Yanbo Wu4 Department of Infectious Disease, Shenzhen Longhua New District Central Hospital, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Liqin Sun3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Man Rao3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Xinyun Jia3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Ying Song3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Guofang Deng1 Department of Lung Disease, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Tianpin Li2 Department of Clinical Laboratory, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Feidi Ye2 Department of Clinical Laboratory, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
,
Yang Zhou3 Department of Infectious Disease No.1, The Third People’s Hospital of Shenzhen, Shenzhen City, Guangdong Province, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Yi Liao5 Department of Primary Health Promotion, Shenzhen Center for Disease Control and Prevention, Shenzhen City, Guangdong Province, People’s Republic of ChinaView further author information
 show all
Pages 905-916 | Published online: 10 Sep 2021

References

  • World Health Organization. Global tuberculosis report 2020 [DB/OL]. World Health Organization; 2020. Available from: http://www.who.int/tb/publications/global_report/en/. Accessed October 14, 2020.
  • Kawkitinarong K, Suwanpimolkul G, Kateruttanakul P, et al. Real-life clinical practice of using the Xpert MTB/RIF assay in Thailand. Clin Infect Dis. 2017;64(S2):S171–S178. doi:10.1093/cid/cix151
  • Horne DJ, Kohli M, Zifodya JS, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6(6):CD009593. doi:10.1002/14651858.CD009593.pub4
  • Meawed TE, Shaker A. Assessment of diagnostic accuracy of Gene Xpert MTB/RIF in diagnosis of suspected retreatment pulmonary tuberculosis patients. Egypt Soc Chest Dis Tuberc. 2018;65:637–641. doi:10.1016/j.ejcdt.2016.04.005
  • Luetkemeyer AF, Firnhaber C, Kendall MA, et al. Evaluation of Xpert MTB/RIF versus AFB Smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings. Clin Infect Dis. 2016;62(9):1081–1088. doi:10.1093/cid/ciw035
  • Chakravorty S, Simmons AM, Rowneki M, et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. Mbio. 2017;8(4):e00812–17. doi:10.1128/mBio.00812-17
  • Dorman SE, Chumacher SGS, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84. doi:10.1016/S1473-3099(17)30691-6
  • Sabi I, Rachow A, Mapamba D, et al. Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study. J Infect. 2018;77:321–327. doi:10.1016/j.jinf.2018.07.002
  • Pan X, Yang S, Deighton MA, Qu Y, Hong L, Su F. A comprehensive evaluation of Xpert MTB/RIF assay with bronchoalveolar lavage fluid as a single test or combined with conventional assays for diagnosis of pulmonary tuberculosis in China: a two-center prospective study. Front Microbiol. 2018;9:444. doi:10.3389/fmicb.2018.00444
  • Piersimoni C, Gherardi G, Gracciotti N, et al. Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence setting. J Clin Tuberc Other Mycobact Dis. 2019;15:100094. doi:10.1016/j.jctube.2019.100094
  • Kendall EA, Kamoga C, Kitonsa PJ, et al. Empiric treatment of pulmonary TB in the Xpert era: correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses. PLoS One. 2019;14(7):e0220251. doi:10.1371/journal.pone.0220251
  • Wu X, Tan G, Gao R, et al. Assessment of the Xpert MTB/RIF Ultra assay on rapid diagnosis of extrapulmonary tuberculosis. Int J Infect Dis. 2019;81:91–96. doi:10.1016/j.ijid.2019.01.050
  • Perlman DC, el-Sadr WM, Nelson ET, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis. 1997;25(2):242–246. PMID: 9332519. doi:10.1086/514546
  • Calligaro GL, Zijenah LS, Peter JG, et al. Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial. Lancet Infect Dis. 2017;17(4):441–450. doi:10.1016/S1473-3099(16)30384-X

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.